Table 2. Comparison between the calculated inflammatory scores and measured clinico-athological features of the studied patient cohort.
Variable | NLR <5 (N) | NLR >5 (N) | P-value | mGPS 0 (N) | mGPS 1 (N) | mGPS 2 (N) | P-value |
---|---|---|---|---|---|---|---|
ALP <130/>130 IU l−1 |
16/18 |
8/15 |
0.36 |
8/5 |
4/3 |
8/17 |
0.17 |
Hb <11/>11 g l−1 |
6/27 |
9/15 |
0.10 |
2/11 |
0/7 |
13/11 |
0.01 |
Number mets>2 |
19/16 |
12/13 |
0.63 |
9/4 |
3/4 |
13/13 |
0.42 |
LDH <250/>250 IU l−1 | 9/14 | 7/8 | 0.83 | 5/6 | 3/2 | 5/15 | 0.51 |
Abbreviations: ALP=alkaline phosphatase; LDH=lactate dehydrogenase; mGPS=modified Glasgow Prognostic Score; NLR=neutrophil–lymphocyte ratio. Associations reaching statistical significance (P<0.05) are highlighted in bold.